Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Change in Inventory (2016 - 2025)

Cumberland Pharmaceuticals (CPIX) has disclosed Change in Inventory for 16 consecutive years, with $205989.0 as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 115.42% to $205989.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.2 million through Dec 2025, up 6.88% year-over-year, with the annual reading at -$2.2 million for FY2025, 6.88% up from the prior year.
  • Change in Inventory hit $205989.0 in Q4 2025 for Cumberland Pharmaceuticals, up from -$630409.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $1.6 million in Q3 2022 to a low of -$2.3 million in Q1 2022.
  • Historically, Change in Inventory has averaged -$517769.9 across 5 years, with a median of -$535986.5 in 2021.
  • Biggest five-year swings in Change in Inventory: skyrocketed 756.09% in 2022 and later tumbled 1073.11% in 2024.
  • Year by year, Change in Inventory stood at -$2.3 million in 2021, then skyrocketed by 118.92% to $427803.0 in 2022, then rose by 3.2% to $441498.0 in 2023, then plummeted by 402.63% to -$1.3 million in 2024, then skyrocketed by 115.42% to $205989.0 in 2025.
  • Business Quant data shows Change in Inventory for CPIX at $205989.0 in Q4 2025, -$630409.0 in Q3 2025, and -$850797.0 in Q2 2025.